Article
Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic…
Oxidative Medicine and Cellular Longevity · 2016 · Adriene A. Paiva, author Helena F. Raposo, author Amarylis C. B. A. Wanschel, author Tarlliza R. Nardelli, author Helena C. F. Oliveira, author Ruchi Shah, Academic Editor
Key facts
| Title | Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death |
|---|---|
| First author | Adriene A. Paiva, author Helena F. Raposo, author Amarylis C. B. A. Wanschel, author Tarlliza R. Nardelli, author Helena C. F. Oliveira, author Ruchi Shah, Academic Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Aug 4, 2016 |
| DOI | 10.1155/2017/1838679 |
| Devices mentioned | K000364, K000365, K003846, K004010, K010362, K011738, K012324, K021513, K022171, K031755, K032552, K040796 and 28 more |
| Product codes mentioned | CGA, CGX, CIT, DHB, FPA, LBR, LFR, LZG, MRZ, NBW, NDC |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1